Lind Global Fund II LP 13D/13G Filings for China SXT Pharmaceuticals, Inc. (SXTC)

Lind Global Fund II LP 13D and 13G filings for China SXT Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-13
4:28 pm
Unchanged
2022-12-3113GChina SXT Pharmaceuticals, Inc.
SXTC
Lind Global Fund II LP0
0.000%
0
(Unchanged)
Filing